BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 5:57 pm Sale |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BIOTECHNOLOGY VALUE FUND L P | 1,353,815 2.900% |
-235,680 (-14.83%) |
Filing |
| 2022-02-14 1:15 pm Purchase |
2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BIOTECHNOLOGY VALUE FUND L P | 1,589,495 5.400% |
451,731 (+39.70%) |
Filing |